Nitric oxide: Its metabolism and clinical implications;Óxido nítrico: Metabolismo e implicaciones clínicas

Medicina Interna de Mexico

Volumn 24, Issue 6, 2008, Pages 397-406

  Duarte Mote, Jesús ^a   Espinosa López, Rogelio F ^b   Díaz Meza, Salvador ^a   Sánchez Rojas, Graciela ^a   Eng Castro, Víctor Enrique Lee ^a   Mijangos Chávez, Janet ^c   Barragán Garfias, Jorge Alberto ^c  

^a HÔPITAL DU BOCAGE   (France)

^b PEMEX   (Mexico)

^c Centro Médico La Raza IMSS

Author keywords

Arginine; Endothelial dysfunction; Nitric oxide; Nitric oxide synthase

Indexed keywords

ALPHA TOCOPHEROL; ARGININE; ASCORBIC ACID; FREE RADICAL; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE; SUPEROXIDE DISMUTASE;

ENDOTHELIAL DYSFUNCTION; HUMAN; IMMUNE SYSTEM; IMMUNOMODULATION; NUTRITIONAL DEFICIENCY; NUTRITIONAL SUPPORT; REVIEW;

EID: 57449112543     PISSN: 01864866     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Martínez AO, Sánchez De Medina F. Arginina, óxido nítrico y función endotelial. Ars Pharm 2004;45(4):303-17.
2. Bravo AME, Araujo AJM, Bustamante QA, Trujillo FJG. Toxici-dad y efecto hipotensor de oxoborolidinona de L-arginina y su modulación por azul de metileno. Comparación con L-arginina, nitrito y nitrato. Arch Cardiol Mex 2001;71:193-98.
3. Sánchez GDJ, Villanueva LGC. Óxído nítrico en el sistema nervioso central. Neuronas nitrérgicas. Revista de Neurología, Neurocirugía y Psiquiatría 2004; 37(2):73-78.
4. Qianhong Li, Yiru Guo. Cardioprotection afforded by Inducible Nitric Oxide Synthase Gene Therapy Is Mediated by Cyclo-oxygenase-2 via a Nuclear Factor-B Dependent Pathway. Circulation 2007;116:1-8.
5. Rudiger A. Mechanisms of sepsis-induced cardiac dysfunction. Crit Care Med 2007;35:1599-608.
6. Kirk SJ, Barbul A. Role of arginine in trauma, sepsis, and im-munity. JPEN 1990;14(5 suppl):226S-229S.
7. Barbul A. Arginine and immune function. Nutrition. 1990;6:53-58.
8. Cynober LA. Amino Acid Metabolism and Therapy in Health and Nutritional Disease. Boca Raton, Fla: CRC Press, 1995;pp:364-68.
9. Zaloga GP. Nutrition in Critical Care. St Louis: Mosby, 1994;pp:107-12.
10. Joyce KS. Arginine immunonutrition in critically ill patients: a clinical dilemma. Am J Crit Care 2004;13:17-23.
11. Lira RV, Arredondo PR. Óxido nítrico: un héroe disfrazado de villano. Elementos 2004;53:11-17.
12. Joyce KS. Op cit.
13. Yvette CL. Exogenous arginine in sepsis. Crit Care Med 2007;35[Suppl.]:S557-S63.
14. Mette MB. Antioxidant supplementation in sepsis and systemic inflammatory response syndrome. Crit Care Med 2007;35[Sup-pl.]:S584-S590.
15. Sabatini L, Wilson C, Lower A, et al. Superoxide dismutase activity in human follicular fluid after controlled ovarian hyper-stimulation in women undergoing in vitro fertilization. Fertil Steril 1999;72:1027-34.
16. Sugino N, Nakata M, Kashida S, et al. Decreased superoxide dismutase expression and increased concentrations of lipid peroxide and prostaglandin F(2 alpha) in the decidua of failed pregnancy. Mol Hum Reprod 2000;6:642-47.
17. Suzuki T, Sugino N, Fukaya T, et al. Superoxide dismutase in normal cycling human ovaries: immunohistochemical localiza-tion and characterization. Fertil Steril 1999;72:720-26.
18. Kasapinovic S, McCallum GP, Wiley MJ, et al. The peroxynitrite pathway in development: phenytoin and benzo_a_pyrene em-bryopathies in inducible nitric oxide synthase knockout mice. Free Radic Biol Med 2004;37:1703-11.
19. Sajal Gupta, Ashok A. The Role of Oxidative Stress in Sponta-neous Abortion and Recurrent Pregnancy Loss: A Systematic Review. Obstet Gynecol Survey 2004;62(5).
20. Hans KB. Antioxidant therapy in critical care. Is the microcir-culation the primary target? Crit Care Med 2007;35[Suppl.]:S577-S583.
21. Bakker J, Grover R, McLuckie A, et al. Administration of the nitric oxide synthase inhibitor NG-methyl-L-arginine hydro-chloride (546C88) by intravenous infusion for up to 72 hours can promote the resolution of shock in patients with severe sepsis: Results of a randomized, double-blind, placeboz-con-trolled multicenter study (study no. 144-002). Crit Care Med 2004;32:1-12.
22. Lopez A, Lorente JA, Steingrub J, et al. Multiple-center, ran-domized, placebo controlled, double-blind study of the nitric oxide synthase inhibitor 546C88: Effect on survival in patients with septic shock. Crit Care Med 2004;32:21-30.
23. Lanone S, Taille C, Boczkowski J, et al. Diaphragmatic fa-tigue during sepsis and septic shock. Intensive Care Med 2005;31:1611-17.
24. Lanone S, Mebazaa A, Heymes C, et al. Muscular contractile failure in septic patients: Role of the inducible nitric oxide synthase pathway. Am J Respir Crit Care Med 2000;162:2308-15.
25. Yeh CL, Hsu CS, Chiu WC, et al. Dietary arginine enhances adhesion molecule and T helper 2 cytokine expression in mice with gut-derived sepsis. Shock 2006;25:155-60.
26. Shingo Y. Mitochondria, endoplasmic reticulum, and alterna-tive pathways of cell death in critical illness. Crit Care Med 2007;35[Suppl.]:S488-S495.